(c) 2024 PillSync.com

24 HR Naproxen 375 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Naproxen sodium extended-release tablets are indicated for the treatment of: rheumatoid arthritis (RA) osteoarthritis (OA) ankylosing spondylitis (AS) tendinitis, bursitis acute gout primary dysmenorrhea (PD) the relief of mild to moderate pain [see Warnings and Precautions (5) ] . Naproxen sodium extended-release tablets are a nonsteroidal anti-inflammatory drug indicated for the treatment of: rheumatoid arthritis (RA)( 1 ) osteoarthritis (OA)( 1 ) ankylosing spondylitis (AS)( 1 ) tendinitis, bursitis ( 1 ) acute gout ( 1 ) primary dysmenorrhea (PD)( 1 ) the relief of mild to moderate pain ( 1 )

Actavis Pharma, Inc.


4 years ago ROUND WHITE Andrx 825 24 HR Naproxen 375 MG Extended Release Oral Tablet

ROUND WHITE Andrx 825

16 HOW SUPPLIED/STORAGE AND HANDLING Naproxen sodium extended-release tablets are available as follows: 375 mg: white, unscored, round tablet imprinted with “ Andrx 825 ”, in bottles of 100, NDC 62037-825-01. Each tablet contains 412.5 mg naproxen sodium, USP equivalent to 375 mg naproxen. 500 mg: white, unscored, capsule-shaped tablet imprinted with “ Andrx 826 ”; in bottles of 75, NDC 62037-826-75. Each tablet contains 550 mg naproxen sodium, USP equivalent to 500 mg naproxen. 750 mg: white, unscored, capsule-shaped, film-coated tablets printed with “ A750 ” on one side and plain on the other side, in bottles of 30, NDC 62037-827-30. Each tablet contains 825 mg naproxen sodium, USP equivalent to 750 mg naproxen. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. PHARMACIST: Dispense in a well-closed container.


More pills like ROUND Andrx 825

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site